Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Feldman

Showing results (191-200 of 2,203) with videos related to

Pageof 221
Sort By:
The British Journal of Dermatology|May 13, 2015
Oral tofacitinib for psoriasis: what happens with interrupted treatment?H Alinia, S R Feldman
Journal of Pediatric Orthopedics|February 1, 1983
Ligamentous disruption of the knee associated with avulsion of the patellar tendon in a 12-year-old boyR Feldman, E D Sedlin
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2003
Neuronal control of heart rate in isolated mouse atriaJ K Choate, R Feldman
Journal of Drugs in Dermatology : JDD|October 31, 2007
Conversion to positive tuberculosis test during etanercept treatment of psoriasisWilliam Sumner, Steven R Feldman
Journal of the American Academy of Dermatology|September 22, 2007
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatmentsJeff Hick, Steven R Feldman
JAMA|January 29, 1973
Multiphasic screeningR Feldman, S L Taller
Urology|September 28, 2014
Editorial commentJoel Sheinfeld, Darren R Feldman
JAMA Dermatology|October 15, 2015
In ReplySteven R Feldman, Kathryn Anderson
Oral Diseases|October 15, 2015
Ultraviolet phototherapy for cutaneous diseases: a concise reviewR Vangipuram, S R Feldman
Drugs in Context|January 20, 2015
The cost of biologics for psoriasis is increasingJudy Cheng, Steven R Feldman
Pageof 221

Showing results (191-200 of 2,203) with videos related to

Sort By:
Pageof 221
The British Journal of Dermatology|May 13, 2015
Oral tofacitinib for psoriasis: what happens with interrupted treatment?H Alinia, S R Feldman
Journal of Pediatric Orthopedics|February 1, 1983
Ligamentous disruption of the knee associated with avulsion of the patellar tendon in a 12-year-old boyR Feldman, E D Sedlin
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2003
Neuronal control of heart rate in isolated mouse atriaJ K Choate, R Feldman
Journal of Drugs in Dermatology : JDD|October 31, 2007
Conversion to positive tuberculosis test during etanercept treatment of psoriasisWilliam Sumner, Steven R Feldman
Journal of the American Academy of Dermatology|September 22, 2007
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatmentsJeff Hick, Steven R Feldman
JAMA|January 29, 1973
Multiphasic screeningR Feldman, S L Taller
Urology|September 28, 2014
Editorial commentJoel Sheinfeld, Darren R Feldman
JAMA Dermatology|October 15, 2015
In ReplySteven R Feldman, Kathryn Anderson
Oral Diseases|October 15, 2015
Ultraviolet phototherapy for cutaneous diseases: a concise reviewR Vangipuram, S R Feldman
Drugs in Context|January 20, 2015
The cost of biologics for psoriasis is increasingJudy Cheng, Steven R Feldman
Pageof 221